IPO Search Results for Alopexx
| Company | Ticker | Business Description | Underwriters | Offer Date |
|---|---|---|---|---|
| Alopexx | ALPX | Phase 2 biotech developing immune therapies for bacterial, fungal, and parasitic infections. | ThinkEquity |
TBA |
| News Results for Alopexx |
|---|
| Nano-cap biotech Alopexx cuts shares offered by 20% ahead of $12 million 09/09/24 |
| US IPO Week Ahead: More micro-caps after a big week for IPOs 02/10/23 |
